Table 2.
Parameters | GAD patients (n = 50) Mean ± SD | Healthy controls (n = 38) Mean ± SD | p value |
---|---|---|---|
DSM‐5 scores | 9.62 ± 1.19 | – | – |
GAD-7 scores | 13.08 ± 4.02 | – | – |
IL-17A (pg/ml) | 77.14 ± 58.30 | 43.50 ± 25.54 | 0.014 |
Male | 73.50 ± 45.83 | 40.81 ± 20.68 | 0.024 |
Female | 81.00 ± 70.57 | 50.72 ± 39.06 | 0.190 |
IL-23A (pg/ml) | 644.90 ± 296.7 | 334.40 ± 176.0 | < 0.001 |
Male | 615.60 ± 311.5 | 310.40 ± 155.2 | < 0.001 |
Female | 701.50 ± 267.5 | 374.30 ± 207.1 | 0.002 |
Significant values are in bold.
Two-tailed unpaired student’s t test was applied for evaluating statistical significance level between mean difference between cases and controls and p < 0.05 was statistically significant.
DSM-5 diagnostic and statistical manual for mental disorders, 5th edition: GAD generalized anxiety disorder, GAD-7 generalized anxiety disorder 7-item scores, SD standard deviation, IL-17A interleukin 17A, IL-23A interleukin 23A.